CD4+ T Cell Depletion During All Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Overview
General Medicine
Authors
Affiliations
The mechanisms underlying CD4(+) T cell depletion in human immunodeficiency virus (HIV) infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated disease. Here, we studied the effect of HIV infection on the activation and depletion of defined subsets of CD4(+) and CD8(+) T cells in the blood, gastrointestinal (GI) tract, and lymph node (LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen deposition to define architectural changes associated with chronic inflammation. The major findings to emerge are the following: the GI tract has the most substantial CD4(+) T cell depletion at all stages of HIV disease; this depletion occurs preferentially within CCR5(+) CD4(+) T cells; HIV-associated immune activation results in abnormal accumulation of effector-type T cells within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell activation in LNs is associated with abnormal collagen deposition. Taken together, these findings define the nature and extent of CD4(+) T cell depletion in lymphoid tissue and point to mechanisms of profound depletion of specific T cell subsets related to elimination of CCR5(+) CD4(+) T cell targets and disruption of T cell homeostasis that accompanies chronic immune activation.
Death and survival of gut CD4 T cells following HIV-1 infection ex vivo.
Mickens K, Dillon S, Guo K, Thompson A, Barrett B, Wood C PNAS Nexus. 2025; 3(11):pgae486.
PMID: 39780917 PMC: 11707799. DOI: 10.1093/pnasnexus/pgae486.
Capriotti Z, Klase Z J Neurovirol. 2024; 30(5-6):451-476.
PMID: 39733092 PMC: 11846772. DOI: 10.1007/s13365-024-01239-2.
Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.
Nazziwa J, Freyhult E, Hong M, Johansson E, Arman F, Hare J Nat Commun. 2024; 15(1):10593.
PMID: 39632834 PMC: 11618498. DOI: 10.1038/s41467-024-54848-0.
The role of pharmacomicrobiomics in HIV prevention, treatment, and women's health.
Swanson E, Basting C, Klatt N Microbiome. 2024; 12(1):254.
PMID: 39627860 PMC: 11613800. DOI: 10.1186/s40168-024-01953-3.
Ebrahimi R, Masouri M, Salehi Amniyeh Khozani A, Hussein D, Nejadghaderi S PLoS One. 2024; 19(10):e0311731.
PMID: 39432486 PMC: 11493255. DOI: 10.1371/journal.pone.0311731.